Free Trial
→ SpaceX will crumble without these 5 companies (From InvestPub) (Ad)tc pixel Free LABS Stock Alerts

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 0.00 (0.00%)
As of 06/12/2026 03:33 PM Eastern
Compare

LABS vs. MDP, TGOD, NINE, WMD, and DB

Should you buy MediPharm Labs stock or one of its competitors? MarketBeat compares MediPharm Labs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MediPharm Labs include Medexus Pharmaceuticals (MDP), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), and Decibel Cannabis (DB). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does MediPharm Labs compare to Medexus Pharmaceuticals?

MediPharm Labs (TSE:LABS) and Medexus Pharmaceuticals (TSE:MDP) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Medexus Pharmaceuticals has higher revenue and earnings than MediPharm Labs. Medexus Pharmaceuticals is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
Medexus PharmaceuticalsC$99.43M1.30C$3.26M-C$0.02N/A

0.3% of MediPharm Labs shares are owned by institutional investors. Comparatively, 3.1% of Medexus Pharmaceuticals shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Comparatively, 9.1% of Medexus Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

MediPharm Labs has a beta of -0.614829, suggesting that its share price is 161% less volatile than the broader market. Comparatively, Medexus Pharmaceuticals has a beta of 0.526834, suggesting that its share price is 47% less volatile than the broader market.

In the previous week, MediPharm Labs had 2 more articles in the media than Medexus Pharmaceuticals. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for Medexus Pharmaceuticals. MediPharm Labs' average media sentiment score of 0.42 beat Medexus Pharmaceuticals' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Neutral
Medexus Pharmaceuticals Neutral

Medexus Pharmaceuticals has a net margin of -0.27% compared to MediPharm Labs' net margin of -20.21%. Medexus Pharmaceuticals' return on equity of -0.52% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Medexus Pharmaceuticals -0.27%-0.52%4.89%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Medexus Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

Medexus Pharmaceuticals beats MediPharm Labs on 11 of the 14 factors compared between the two stocks.

How does MediPharm Labs compare to Green Organic Dutchman?

Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends.

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, MediPharm Labs had 2 more articles in the media than Green Organic Dutchman. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for Green Organic Dutchman. MediPharm Labs' average media sentiment score of 0.42 beat Green Organic Dutchman's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the news media.

Company Overall Sentiment
Green Organic Dutchman Neutral
MediPharm Labs Neutral

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Green Organic DutchmanN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

Summary

MediPharm Labs beats Green Organic Dutchman on 7 of the 11 factors compared between the two stocks.

How does MediPharm Labs compare to Delta 9 Cannabis?

Delta 9 Cannabis (CVE:NINE) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, MediPharm Labs had 2 more articles in the media than Delta 9 Cannabis. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for Delta 9 Cannabis. MediPharm Labs' average media sentiment score of 0.42 beat Delta 9 Cannabis' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the news media.

Company Overall Sentiment
Delta 9 Cannabis Neutral
MediPharm Labs Neutral

Delta 9 Cannabis has higher earnings, but lower revenue than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$12.87M6.94C$4.69MC$0.0519.07
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

Delta 9 Cannabis has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Delta 9 Cannabis' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Delta 9 CannabisN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Delta 9 Cannabis beats MediPharm Labs on 7 of the 12 factors compared between the two stocks.

How does MediPharm Labs compare to WeedMD?

MediPharm Labs (TSE:LABS) and WeedMD (CVE:WMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

MediPharm Labs has higher revenue and earnings than WeedMD. MediPharm Labs is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A

In the previous week, MediPharm Labs had 2 more articles in the media than WeedMD. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for WeedMD. MediPharm Labs' average media sentiment score of 0.42 beat WeedMD's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Neutral
WeedMD Neutral

WeedMD has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. WeedMD's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
WeedMD N/A N/A N/A

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

MediPharm Labs beats WeedMD on 7 of the 12 factors compared between the two stocks.

How does MediPharm Labs compare to Decibel Cannabis?

MediPharm Labs (TSE:LABS) and Decibel Cannabis (CVE:DB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

MediPharm Labs has a beta of -0.614829, suggesting that its share price is 161% less volatile than the broader market. Comparatively, Decibel Cannabis has a beta of -0.07358, suggesting that its share price is 107% less volatile than the broader market.

Decibel Cannabis has a consensus target price of C$0.18, suggesting a potential upside of 52.17%. Given Decibel Cannabis' stronger consensus rating and higher possible upside, analysts plainly believe Decibel Cannabis is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Decibel Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

0.3% of MediPharm Labs shares are held by institutional investors. Comparatively, 0.7% of Decibel Cannabis shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 1.1% of Decibel Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, MediPharm Labs had 2 more articles in the media than Decibel Cannabis. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for Decibel Cannabis. MediPharm Labs' average media sentiment score of 0.42 beat Decibel Cannabis' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Neutral
Decibel Cannabis Neutral

Decibel Cannabis has a net margin of -3.78% compared to MediPharm Labs' net margin of -20.21%. Decibel Cannabis' return on equity of -1.05% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Decibel Cannabis -3.78%-1.05%3.04%

Decibel Cannabis has higher revenue and earnings than MediPharm Labs. Decibel Cannabis is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
Decibel CannabisC$121.32M0.55-C$1.03M-C$0.01N/A

Summary

Decibel Cannabis beats MediPharm Labs on 12 of the 17 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

Export
MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$31.87MC$2.39BC$6.52BC$12.19B
Dividend YieldN/A2.94%2.67%6.19%
P/E Ratio-3.755.0224.0036.94
Price / Sales0.741,639.28516.4210.45
Price / Cash1.3010.1827.4882.29
Price / Book0.9110.4110.744.47
Net Income-C$12.05MC$20.27BC$3.57BC$299.09M
7 Day PerformanceN/A-0.99%0.58%0.65%
1 Month PerformanceN/A5.83%1.48%-0.08%
1 Year PerformanceN/A15.90%25.41%41.90%

MediPharm Labs Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.08
flat		N/A-11.8%C$31.87MC$43.28MN/A130
MDP
Medexus Pharmaceuticals
N/AC$3.91
-1.3%		N/A+36.9%C$126.29MC$99.43MN/A98
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37MN/A41
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%		N/A+0.0%C$89.36MC$12.87M19.07940
WMD
WeedMD
N/AC$0.28
-1.8%		N/A+0.0%C$67.82MC$27.53MN/A628

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:LABS) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel